Literature DB >> 21930273

NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages.

Veerle Bieghs1, Patrick C N Rensen, Marten H Hofker, Ronit Shiri-Sverdlov.   

Abstract

Macrophage infiltration into the atherosclerotic lesion is known to play a central role in the initiation of atherosclerosis. In contrast, the role of macrophages during the etiology of non-alcoholic steatohepatitis (NASH) has been considered to be merely a late consequence of steatosis. However, recent insights suggest that macrophage activation and infiltration is also an early initiating event in NASH and thereby point to the shared etiology of atherosclerosis and NASH. In this review, we put forward the hypothesis that NASH and atherosclerosis are actually two aspects of a shared disease, involving the local presence of activated macrophages. We will review the current data supporting the shared mechanisms and also discuss the implications. Crown
Copyright © 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930273     DOI: 10.1016/j.atherosclerosis.2011.08.041

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  43 in total

1.  Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice.

Authors:  Rongying Ou; Jia Liu; Mingfen Lv; Jingying Wang; Jinmeng Wang; Li Zhu; Liang Zhao; Yunsheng Xu
Journal:  Endocrine       Date:  2017-04-06       Impact factor: 3.633

2.  Ceacam1 deletion causes vascular alterations in large vessels.

Authors:  Sonia M Najjar; Kelly J Ledford; Simon L Abdallah; Alexander Paus; Lucia Russo; Meenakshi K Kaw; Sadeesh K Ramakrishnan; Harrison T Muturi; Christian K Raphael; Sumona Ghosh Lester; Garrett Heinrich; Sandrine V Pierre; Ralf Benndorf; Veronika Kleff; Ayad A Jaffa; Emile Lévy; Guillermo Vazquez; Ira J Goldberg; Nicole Beauchemin; Rosario Scalia; Süleyman Ergün
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-25       Impact factor: 4.310

3.  Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is Influenced by CCR2.

Authors:  Elizabeth C Stahl; Evan R Delgado; Frances Alencastro; Samuel T LoPresti; Patrick D Wilkinson; Nairita Roy; Martin J Haschak; Clint D Skillen; Satdarshan P Monga; Andrew W Duncan; Bryan N Brown
Journal:  Am J Pathol       Date:  2019-12-13       Impact factor: 4.307

4.  Ethnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis.

Authors:  Rajesh Tota-Maharaj; Michael J Blaha; Irfan Zeb; Ronit Katz; Ron Blankstein; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir
Journal:  Mayo Clin Proc       Date:  2014-03-07       Impact factor: 7.616

Review 5.  Innate immune cells in the adipose tissue.

Authors:  Kyoung-Jin Chung; Marina Nati; Triantafyllos Chavakis; Antonios Chatzigeorgiou
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

6.  Macrophage autophagy regulated by miR-384-5p-mediated control of Beclin-1 plays a role in the development of atherosclerosis.

Authors:  Beiyun Wang; Yuan Zhong; Dong Huang; Jingbo Li
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

7.  Plasma cathepsin D levels: a novel tool to predict pediatric hepatic inflammation.

Authors:  Sofie M A Walenbergh; Tom Houben; Tim Hendrikx; Mike L J Jeurissen; Patrick J van Gorp; Anita C E Vreugdenhil; Marlou P Adriaanse; Wim A Buurman; Marten H Hofker; Antonella Mosca; Patrick J Lindsey; Anna Alisi; Daniela Liccardo; Nadia Panera; Ger H Koek; Valerio Nobili; Ronit Shiri-Sverdlov
Journal:  Am J Gastroenterol       Date:  2015-03-03       Impact factor: 10.864

8.  Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides.

Authors:  Xuemei Jia; Stephen Iwanowycz; Junfeng Wang; Fatma Saaoud; Fang Yu; Yuzhen Wang; Jun Hu; Saurabh Chatterjee; Qian Wang; Daping Fan
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-16

Review 9.  Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.

Authors:  Licia Polimeni; Maria Del Ben; Francesco Baratta; Ludovica Perri; Fabiana Albanese; Daniele Pastori; Francesco Violi; Francesco Angelico
Journal:  World J Hepatol       Date:  2015-06-08

10.  Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.

Authors:  Y Wang; E T Parlevliet; J J Geerling; S J L van der Tuin; H Zhang; V Bieghs; A H M Jawad; R Shiri-Sverdlov; I Bot; S C A de Jager; L M Havekes; J A Romijn; K Willems van Dijk; P C N Rensen
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.